CD2314
| Clinical data | |
|---|---|
| Other names | CD-2314; CD 2314 |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C23H24O2S |
| Molar mass | 364.50 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
CD2314 is a drug which acts as a retinoic acid receptor β (RARβ) agonist. It is used for research into the function of RARβ and promotes nerve repair following injury.[1][2]
References
- ^ Duprey-Díaz MV, Blagburn JM, Blanco RE (9 September 2016). "Exogenous Modulation of Retinoic Acid Signaling Affects Adult RGC Survival in the Frog Visual System after Optic Nerve Injury". PLOS ONE. 11 (9) e0162626. Bibcode:2016PLoSO..1162626D. doi:10.1371/journal.pone.0162626. PMC 5017682. PMID 27611191.
- ^ Miro Estruch I, Melchers D, Houtman R, de Haan LH, Groten JP, Louisse J, et al. (September 2017). "Characterization of the differential coregulator binding signatures of the Retinoic Acid Receptor subtypes upon (ant)agonist action". Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1865 (9): 1195–1206. doi:10.1016/j.bbapap.2017.06.011. PMID 28642153.
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.